HealthQuill Precision Medicine
US regulator, the FDA has approved Gilead Sciences, Inc.'s supplemental new drug application for treating chronic hepatitis B virus in paediatric patients six years of age and older.
Drugs Health

Scientists map 641 new schizophrenia genes using “Social Network” for DNA

HQ Team June 24,2026: Scientists have discovered 641 previously unknown genes linked to schizophrenia, using a revolutionary method that maps how genes “talk” to.

Read More
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Uncategorized

Bayer and Kumquat Biosciences ink $1.3 billion deal to develop cancer inhibitor

HQ Team August 13, 2025: Bayer and Kumquat Biosciences, a clinical-stage biotech, announced an exclusive global license and collaboration agreement worth $1.3 billion.

Read More
Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and a video game using the device, according to a video posted by billionaire Elon Musk’s X platform.
Health Research

Mid-frontal brain folds key to schizophrenia: Zurich study finds

HQ Team February 27, 2025: The uniformity of brain folding in the mid-frontal area suggests a developmental trait common to people with schizophrenia,.

Read More